Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

Conditions: Polymyalgia Rheumatica Interventions: Biological: Secukinumab Sponsors: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials